Galapagos NV (GLPG)
29.63
+0.08
(+0.27%)
USD |
NASDAQ |
May 17, 16:00
29.64
+0.02
(+0.05%)
After-Hours: 20:00
Galapagos Gross Profit Margin (Quarterly): 95.92% for March 31, 2024
Gross Profit Margin (Quarterly) Chart
Historical Gross Profit Margin (Quarterly) Data
Date | Value |
---|---|
March 31, 2024 | 95.92% |
December 31, 2023 | |
September 30, 2023 | 95.25% |
June 30, 2023 | 97.10% |
March 31, 2023 | |
December 31, 2022 | |
September 30, 2022 | 98.24% |
Date | Value |
---|---|
June 30, 2022 | 98.09% |
March 31, 2022 | 97.86% |
December 31, 2021 | |
September 30, 2021 | 99.18% |
June 30, 2021 | 99.93% |
March 31, 2021 | 99.97% |
Gross Profit Margin Definition
Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.
Gross Profit Margin (Quarterly) Range, Past 5 Years
95.25%
Minimum
Sep 2023
99.97%
Maximum
Mar 2021
97.95%
Average
98.09%
Median
Jun 2022
Gross Profit Margin (Quarterly) Benchmarks
UCB SA | -- |
Mithra Pharmaceuticals SA | -- |
Nyxoah SA | 62.74% |
Celyad Oncology SA | -- |
MDxHealth SA | 60.82% |
Gross Profit Margin (Quarterly) Related Metrics
Return on Equity | 10.32% |
Return on Assets | 6.23% |
Return on Invested Capital | 10.32% |
Operating Margin (Quarterly) | -53.07% |
Return on Net Operating Assets | 57.42% |